Decision to fund pancreatic enzymes modified-release granules (Creon Micro)
We’re pleased to announce a decision to fund pancreatic enzymes modified-release granules (Creon Micro) from 1 June 2020 for the treatment of pancreatic enzyme insufficiency, through an agreement with Mylan New Zealand Limited.
This formulation allows for dosing with small amounts of enzymes, ie smaller doses than those contained in the funded capsules, that can be measured prior to mixing with food or fluids. We estimate that around 95 patients per year will benefit from treatment.
Any changes to the original proposal?
No changes were made to the proposal following consultation feedback.
Who we think will be most interested
- Children with cystic fibrosis, their guardians and whānau
- Paediatricians, respiratory physicians, gastroenterologists, respiratory nurses, pharmacists and other clinicians and health professionals involved in the management of cystic fibrosis
- Pharmaceutical suppliers
Detail about this decision
Pancreatic enzymes modified-release granules (Creon Micro) will be listed in Section B and Part II of Section H of the Pharmaceutical Schedule from 1 June 2020 at the following price and subsidy (ex-manufacturer, excluding GST):
Price and subsidy
Modified release granules pancreatin 60.12 mg (amylase 3,600 Ph Eur U, lipase 5,000 Ph Eur U, protease 200 Ph Eur U)
20 g OP
There will be no funding restrictions for Creon Micro.
Our response to what you told us
We’re really grateful for the time people took to respond to this consultation. All responses received were supportive of the proposal.
There was a concern raised that dosing and administration aids may possibly be lost. We note that each bottle of Creon Micro contains a dosing scoop. If this is lost, guidance could be sought from the manufacturer (Mylan(external link)), or alternatively patients may need a new prescription for a new bottle of granules to obtain a new scoop.
If you have any questions about this decision, you can email us at firstname.lastname@example.org; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 660 050.